The Covax global programme, which has relied heavily on AstraZeneca vaccines, said on Monday it has struck a deal to buy 500 million doses of Moderna’s Covid-19 jabs.
The doses will broaden out the portfolio of vaccines under Covax, which seeks to ensure poor countries have equitable access to vaccines to combat the pandemic. The announcement is good news for countries like Kenya, especially after the programme was thrown into disarray after India banned export of the vaccine…
